Sort   by:  
 Page size 
UnknownPrimary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.
Not available
S-EPMC5286940 | biostudies-literature
UnknownMild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences.
Not available
S-EPMC5393157 | biostudies-literature
UnknownA pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.
Not available
S-EPMC4800694 | biostudies-literature
UnknownEfficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.
Not available
S-EPMC4380721 | biostudies-literature
Sort   by:  
 Page size